Download presentation
Presentation is loading. Please wait.
Published byClifford Howard Modified over 5 years ago
1
African Americans, Kidney Disease, and Drug Development: A Regulatory Perspective
Carolina Panico, Aliza Thompson American Journal of Kidney Diseases Volume 72, Issue 5, Pages S33-S36 (November 2018) DOI: /j.ajkd Copyright © Terms and Conditions
2
Figure 1 Demographics of efficacy trials by race for Veltassa (patiromer). Data source: US Food and Drug Administration.15 American Journal of Kidney Diseases , S33-S36DOI: ( /j.ajkd ) Copyright © Terms and Conditions
3
Figure 2 Demographics of efficacy trials by race for Entresto (sacubitril/valsartan). Data source: US Food and Drug Administration.15 ∗All other races combined. American Journal of Kidney Diseases , S33-S36DOI: ( /j.ajkd ) Copyright © Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.